Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2017Visceral MedicineOpen Access

Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RARaja AtreyaFriedrich-Alexander-Universität Erlangen-Nürnberg
Markus F. Neurath
Markus F. NeurathFriedrich-Alexander-Universität Erlangen-Nürnberg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Atreya et al. (2017) studied this question.

synapsesocial.com/papers/6a76df15e29fd788c9f6e445https://doi.org/10.1159/000458006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium2016 · 328 citations
  2. 2Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target2015 · 1,861 citations